Focus Financial Network’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$816K Buy
17,017
+8,685
+104% +$373K 0.03% 384
2026
Q1
$316K Buy
8,332
+600
+8% +$28.4K 0.01% 586
2025
Q4
$393K Buy
7,732
+1,768
+30% +$90.4K 0.01% 510
2025
Q3
$331K Buy
5,964
+405
+7% +$23.7K 0.01% 571
2025
Q2
$384K Sell
5,559
-866
-13% -$58.9K 0.02% 498
2025
Q1
$446K Sell
6,425
-2,445
-28% -$202K 0.02% 447
2024
Q4
$763K Buy
8,870
+750
+9% +$81.1K 0.03% 326
2024
Q3
$967K Buy
8,120
+227
+3% +$30.3K 0.04% 278
2024
Q2
$1.07M Buy
7,893
+3,885
+97% +$515K 0.05% 262
2024
Q1
$492K Buy
+4,008
New +$477K 0.02% 379
2023
Q4
Sell
-2,860
Closed -$260K 736
2023
Q3
$260K Buy
+2,860
New +$252K 0.01% 504

Other funds holding NVO

Focus Financial Network's NVO Position: Q2 2026 in Review

Focus Financial Network increased its Novo Nordisk (NVO) stake by 104% in Q2 2026, buying an estimated $373K and bringing the position to 17,017 shares worth $816K. The position accounts for 0.03% of the portfolio, ranked #384.

Focus Financial Network first reported a position in NVO in Q3 2023 and has held it in 11 quarters since. The position peaked at $1.07M in Q2 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Focus Financial Network held 17,017 shares of Novo Nordisk worth $816K as of Q2 2026.
  • Focus Financial Network bought 8,685 Novo Nordisk shares in Q2 2026, an estimated $373K.
  • Novo Nordisk made up 0.03% of Focus Financial Network's portfolio in Q2 2026, its #384 holding.
  • Focus Financial Network first reported a position in Novo Nordisk in Q3 2023 and has held it in 11 quarters since.
  • Focus Financial Network's Novo Nordisk position peaked at $1.07M in Q2 2024.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Focus Financial Network's 13F filing for Q2 2026, filed 9 Jul 2026.